Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) FCF Margin (2016 - 2025)

Bio-Techne has reported FCF Margin over the past 17 years, most recently at 25.85% for Q4 2025.

  • Quarterly results put FCF Margin at 25.85% for Q4 2025, down 25.0% from a year ago — trailing twelve months through Dec 2025 was 18.35% (down 292.0% YoY), and the annual figure for FY2025 was 21.03%, up 66.0%.
  • FCF Margin for Q4 2025 was 25.85% at Bio-Techne, up from 7.75% in the prior quarter.
  • Over the last five years, FCF Margin for TECH hit a ceiling of 2326.25% in Q3 2022 and a floor of 7.75% in Q3 2025.
  • Median FCF Margin over the past 5 years was 22.77% (2022), compared with a mean of 137.73%.
  • Biggest five-year swings in FCF Margin: soared 230981bps in 2022 and later tumbled -230972bps in 2023.
  • Bio-Techne's FCF Margin stood at 33.73% in 2021, then plummeted by -36bps to 21.46% in 2022, then rose by 17bps to 25.04% in 2023, then grew by 4bps to 26.1% in 2024, then dropped by -1bps to 25.85% in 2025.
  • The last three reported values for FCF Margin were 25.85% (Q4 2025), 7.75% (Q3 2025), and 29.44% (Q2 2025) per Business Quant data.